ExploreWatchlistsPricing
  1. US-listed companies
  2. Sonnet BioTherapeutics Holdings, Inc.
  3. Financials
  4. Net income margin (%)

Sonnet BioTherapeutics Holdings, Inc. (SONN)

Market cap
$1.26
P/E ratio
SummaryFinancials
Period EndNet income margin (%) YoY (%)
Sep 30, 2025-1,601.1-95.99%
Sep 30, 2024-39,929.3+112.02%
Sep 30, 2023-18,832.7+121.73%
Sep 30, 2022-8,493.3+64.41%
Sep 30, 2021-5,166+8684.55%
Dec 31, 2019-58.8+248.44%
Dec 31, 2018-16.9+2.91%
Dec 31, 2017-16.4-24.65%
Dec 31, 2016-21.8-23.97%
Dec 31, 2015-28.6+49.20%
Dec 31, 2014-19.2-69.65%
Dec 31, 2013-63.2+37.42%
Dec 31, 2012-46-38.97%
Dec 31, 2011-75.4

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat